Lacroix Falgarde, France

Nicolas Congy

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Nicolas Congy

Introduction

Nicolas Congy is a notable inventor based in Lacroix Falgarde, France. He has made significant contributions to the field of immunology, particularly in the development of monoclonal chimeric immunoglobulins. With a total of 2 patents to his name, Congy has focused on innovative methods and kits for determining anti-HLA antibodies.

Latest Patents

Congy's latest patents include the "Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulin." This patent describes a method for determining the quantity of anti-HLA antibodies in a liquid medium containing antibodies. Another significant patent is the "Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin." This invention details a monoclonal chimeric immunoglobulin with human constant parts in both heavy and light chains, along with a process for standardizing the screening and quantification of anti-HLA antibodies.

Career Highlights

Throughout his career, Nicolas Congy has worked with esteemed institutions such as the Centre Hospitalier Universitaire de Toulouse and Université Paul Sabatier Toulouse III. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Congy has collaborated with notable colleagues, including Antoine Blancher and Jean-Gerard Tiraby. These partnerships have played a crucial role in the development of his innovative patents.

Conclusion

Nicolas Congy is a distinguished inventor whose work in immunology has led to significant advancements in the understanding and quantification of anti-HLA antibodies. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…